Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-cell Repertoire Kinetics Following TIV in Young Adults
NCT02987374Phase 4Completed
- Sponsor
- Stanford University
- Start
- May 2012
- Primary completion
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 4, open-label trial of Fluzone Trivalent in influenza, sponsored by Stanford University. Primary endpoint: Number of Participants Who Received Influenza Vaccine at 180 days. Started May 2012; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02987374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02987374.